Melatonin is used to help regulate sleep-wake cycles and treat insomnia, helping people fall asleep more easily and improving sleep quality.[2] Circadin is currently approved and in use across 130 indications[4].[1]
Circadin is one of 1975 small molecule programs targeting Insulin resistance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Circadin
Avastin
Prolia
Blenoxane
Voltaren
Lupron
Recentin
Zinecard
Tricor
QS21
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details